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Abstract
Renal oncocytomas accounts for 3% to 9% of primary renal neo-
plasms. The coexistence of renal cell carcinoma (RCC) within 
the oncocytoma is extremely rare. We report the case of an asy-
ptomatic 74-year-old man with papillary RCC within oncocytoma 
managed with left radical nephrectomy.
Introduction 
Renal oncocytomas are rare benign neoplasms accounting 
for 3% to 9% of all primary renal neoplasms.1 Although 
most are asymptomatic and discovered incidentally, a few 
symptomatic patients may complain of hematuria, flank 
pain, or palpable mass.1,2 Oncocytomas are usually unifo-
cal, but multifocal and bilateral appearances of the onco-
cytomas and concomitant renal cell carcinoma (RCC) have 
been reported.3 To our knowledge, only 3 cases of papil-
lary subtype of RCC within a renal oncocytomahave been 
previously described in the literature.4-6 In this case report, 
we present the fourth case of papillary RCC embedded in 
a renal oncocytoma. 
Case report 
A 74-year-old man with no medical history was referred to 
us due to a hyperecoic left kidney mass on routine abdomi-
nal ultrasound. He had a 50-packets/year smoking history. 
Physical examination was unremarkable, and laboratory 
findings were within normal values, with hemoglobin of 
14.8 g/dL and creatinine 1.02 mg/dL. His computed tomog-
raphy scan of the abdomen confirmed a 6 × 5-cm left renal 
mass located between the renal hilum and lower pole.
He underwent a left radical nephrectomy through a left 
flank incision without perioperative complications. The 
patient fared well postoperatively and was discharged on 
postoperative day 3. 
Specimen examination revealed a 5 × 5 × 4.5-cm hem-
orrhagic, necrotic, gray, brown and red mass at the lower 
pole of the left kidney. There was another 1.7 × 1.5 × 1.5-
cm yellow and orange colored mass within the tumoural 
mass. Microscopic examination revealed the outer zone 
of the tumoural mass as oncocytoma. There was a 1.5-cm 
uncapsulated, papillary and eosinophilic mass within the 
oncocytoma. Immunohistochemically, E-cadherin and Pax2 
stained positively in oncocytoma areas. CD117 staining was 
weakly positive (Fig. 1). The papillary mass’ immunophe-
notypic expression had positive vimentin and cytokeratin 
7 – we concluded he had papillary RCC (Fig. 2).
The tumour stage was assessed as T1N0MX according to 
the American Joint Committee on Cancer (AJCC) classifica-
tion. The patient did not receive adjuvant therapy. No recur-
rence or metastasis was seen at the 18-month follow-up.
Discussion 
Renal oncocytoma, first described by Zippel in 1942, is 
a relatively non-frequent neoplasms arising from inter-
calating cells of the cortical collecting ducts.7 Clinically, 
oncocytomas are found incidentally, but hematuria is the 
most common complaint in symptomatic patients.8 The 
diagnosis of these benign lesions is generally achieved by 
computed tomography or magnetic resonance imaging.7 
Unfortunately, most renal oncocytomas cannot be differ-
entiated from malignant RCC by clinical or radiographic 
criteria. Common imaging findings are central stellate scar 
and spoke-wheel pattern of feeding arteries, but these find-
ings are usually unreliable for the preoperative differen-
tial diagnosis.9 Therefore, these tumours should be treated 
operatively, like RCC, with radical nephrectomy, nephron-
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sparing surgery and minimally invasive approaches, such 
as cryo- and radiofrequency ablation.9,10
Papillary RCC comprises 10% of RCCs and has a better 
prognosis when compared with clear cell RCC.1 Two sub-
types of papillary RCC have been described. Type 1 tumours 
have papillae covered by a single layer of small uniform 
cells with scant amphophilic to basophilic cytoplasm and 
low nuclear grade. In type 2 tumours, the tumours include 
columnar cells with eosinophilic cytoplasm and they have 
a high nuclear grade.1,11
Renal oncocytoma and RCC can coexist in the same or 
the contralateral kidney.6 Chromophobe RCC and oncocy-
toma are suspected to be closely related and are thought to 
show a similar distal tubular phenotype. However, oncocy-
tomas and papillary RCCs originate from different cells and 
the presence of a papillary RCC within an oncocytoma is 
extremely rare. We were only able to identify 3 case reports 
with this coexistence.4-6 All tumours were detected inciden-
tally during imaging studies for other reasons and none of 
these were larger than 4 cm. Two of these cases were treated 
with partial nephrectomy and one with radical nephrectomy. 
In our case, we performed radical nephrectomy because the 
5 cm in diameter tumour was close to the renal hilum. This 
case, which has the largest renal oncocytoma and papillary 
RCC diameter also had the longest follow-up period among 
the cases reported so far (Table 1). 
Conclusion 
Sometimes chromophobe RCC arises within a renal onco-
cytoma. However, the combination of papillary RCC and 
oncocytoma is extremely rare because these tumours are 
developed from different origins. This case shows us once 
again that although very rare, renal oncocytoma may con-
tain malignant tumour, such as RCC. Therefore, even if the 
radiological screening strongly suggests that the tumour is 
oncocytoma, this rare entity should also be kept in mind. 
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Fig. 1. Immunohistochemical staining of oncocytoma areas (A) Positive 
E-cadherin expression (×400). (B) Positive Pax2 (×200). (C) Weakly positive 
CD117 expression (×400).
Fig. 2. (A) On hematoxylin-eosin (H&E) staining (×40), papillary renal cell 
carcinoma (RCC) (arrow) within the renal oncocytoma (arrowhead). (B) 
Oncocytoma (arrowhead) and papillary RCC (arrow) on H&E staining (×100). (C) 
Positive staining with vimentin (×200) in papillary RCC (arrow), negative staining 
in oncocytoma (arrowhead). (D) Positive staining with cytokeratin 7 (×200) in 
papillary RCC (arrow), negative staining in oncocytoma (arrowhead).
Table 1. Summary of the cases reported so far and current case
Age (years) Sex Tumour size (PRCC/RO) PRCC subtype Tumour side Treatment Follow-up (months)
Roswell et al.4 75 Male 7/15 mm Type 1 Left Partial nx. n/a
Floyd et al.5 73 Female 1.5/36 mm Type 2 Left Partial nx. n/a
Sebjen et al.6 68 Male 10/35 mm Type 2 Right Radical nx. 8
Current case 74 Male 15/50 mm Type 2 Left Radical nx. 18
PRCC: papillary RCC; RO: renal oncocytoma; nx.: nephrectomy.
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